NCT06326983View on ClinicalTrials.gov

Opioid Sparing Anesthesia Care for Pediatric Patients Having Tonsil Surgery

NARecruitingINTERVENTIONAL
Enrollment

58

Participants

Timeline

Start Date

May 9, 2024

Primary Completion Date

December 31, 2025

Study Completion Date

April 1, 2026

Conditions
TonsillitisPost-operative Nausea and Vomiting (PONV)Emergence DeliriumOpioid Analgesic Adverse ReactionAnesthesiaPain
Interventions
DRUG

Dexmedetomidine

Dexmedetomidine (1mcg/kg bolus given intravenously at induction of anesthesia

DRUG

Acetaminophen

Acetaminophen (12.5mg/kg with a maximum dose of 1 gram given intravenously at induction of anesthesia).

DRUG

Ketorolac

Ketorolac 0.5mg/kg with a max dose of 30mg intravenously at the end of surgery.

DRUG

Morphine

Morphine (0.1mg/kg given intravenously at induction of anesthesia)

Trial Locations (1)

02453

RECRUITING

Boston Children's Hospital, Waltham

All Listed Sponsors
lead

Boston Children's Hospital

OTHER